Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

HonorHealth Research Institute's new downtown Phoenix laboratory has produced its first study, centered on a promising new ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

This innovative approach challenges the standard treatment path for many cancer patients, which typically includes surgery followed by chemotherapy and radiation. For patients facing difficult ...

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies ...